Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease
- 20 February 2001
- journal article
- clinical trial
- Published by Elsevier BV in Neuroscience Letters
- Vol. 300 (3), 157-160
- https://doi.org/10.1016/s0304-3940(01)01586-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's diseaseActa Neurologica Scandinavica, 2009
- A 5-month, randomized, placebo-controlled trial of galantamine in ADNeurology, 2000
- Long-Term Tacrine Treatment in Three Mild Alzheimer PatientsAlzheimer Disease & Associated Disorders, 1998
- A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's diseaseNeurology, 1998
- Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brainBrain Research, 1992
- Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's diseaseJournal of Neural Transmission, 1989
- Chapter 35 The role of nicotinic receptors in the pathophysiology ofAlzheimer's diseaseProgress in brain research, 1989
- Cerebrospinal fluid cholinesterases in aging and in dementia of the alzheimer typeAnnals of Neurology, 1988
- Acetylcholinesterase activity in ventricular and cisternal csf of dogs: Effect of chlorpromazineJournal of Neuroscience Research, 1978
- Is acetylcholinesterase secreted from central neurons into the cerebrospinal fluid?Neuroscience, 1976